7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
https://doi.org/10.1093/qjmed/hcab113.048
Copy DOIPublication Date: Oct 1, 2021 |
Abstract Background Necrotizing enterocolitis (NEC) is one of the most dangerous gastrointestinal diseases that affects neonates especially preterm neonates. It is considered one of the oxygen radical diseases of neonatology as it is attributed to accumulation of reactive oxygen species (ROS) and free radicals leading to cellular oxidative damage. Melatonin proved to be an effective antioxidant and free radical scavenger with no documented side effects. Objective We aimed to evaluate the efficacy and safety of melatonin as adjuvant therapy in feeding intolerance and prophylaxis against NEC. Methods This was an interventional trial conducted on 90 preterm neonates with feeding intolerance. They were simply randomized to Group I that received melatonin treatment (n = 45) and Group II that received traditional treatment only (n = 45). Melatonin was administered at a total dose of 20 mg enterally in two divided doses of 10 mg each, 1 h apart. Tumor necrosis factor alpha (TNFα) level was assessed in patients 72 hours after starting treatment and both groups were observed for incidence of NEC, clinical improvement of feeding intolerance and time needed to reach full intake. Results Group I reported significantly less incidence of NEC in Group I treated with melatonin. Improved tolerance to feeds was observed in Group I resulting in earlier achievement of full enteral intake. Significantly higher levels of TNF alpha were found in Group II that received traditional treatment, indicative of higher level of oxidative stress and free radicals. Conclusion Melatonin in an effective and safe antioxidant and free radical scavenger associated with improvement of clinical and laboratory data in preterm infants with feeding intolerance and significantly less incidence of NEC.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.